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2. ABSTRACT and KEYWORDS 
 
Background: The time course of atherosclerosis burden in distinct vascular territories 
remains poorly understood. 
Objectives: We longitudinally evaluated the natural history of atherosclerotic progression 
in two different arterial territories using high spatial resolution magnetic resonance imaging 
(HR-MRI), a powerful, safe and non-invasive tool 
Methods and results: We prospectively studied a cohort of 30 patients (mean age 68.3, 
n=9 females) with high Framingham general cardiovascular disease 10-year risk score 
(29.5%) and standard medical therapy with mild to moderate atherosclerosis intra-
individually at the level of both carotid and femoral arteries. A total of 178 HR-MRI studies 
of carotid and femoral arteries performed at baseline, one and two years follow-up were 
evaluated in consensus reading by two experienced readers for lumen area (LA), total 
vessel area (TVA), vessel wall area (VWA=TVA-LA), and normalized wall area index 
(NWI=VWA/TVA).  
At the carotid level, LA decreased (-3.19%/year, p=0.018), VWA increased (+3.83%/year, 
p=0.019) and TVA remained unchanged. At the femoral level, LA remained unchanged, 
VWA and TVA increased (+5.23%/year and +3.11%/year, both p<0.01), and NWI 
increased for both carotid and femoral arteries (+2.28%/year, p=0.01, and +1.8%/year, 
p=0.033).  
Conclusion: The atherosclerotic burden increased significantly in both carotid and femoral 
arteries. However, carotid plaque progression was associated with negative remodeling, 
whereas the increase of femoral plaque burden was compensated by positive remodeling. 
This finding could be related to anatomic and flow differences and/or to the distinct degree 
of obstruction in the two arterial territories. 
Keywords: atherosclerosis, carotid artery, femoral artery, MRI, remodeling 
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3. INTRODUCTION 
 
Recently, there has been an increasing interest in studies of non-coronary atherosclerosis. 
Determinants of this renewed interest are the perception that atherosclerosis represents a 
systemic disease with manifestations in multiple vascular beds and that the presence of 
peripheral vascular disease is one of the most formidable prognostic predictors of 
cardiovascular morbidity and mortality1.  
Progression of atherosclerosis has been studied extensively post mortem and in vivo in 
coronary arteries using invasive methods (e.g., angiography, IVUS and emerging non-
invasive techniques). Although angiography remains the mainstay procedure for 
evaluation of flow-limiting stenosis in both coronary and peripheral artery disease, in the 
clinical research field, there is increasing interest in non-invasive imaging techniques that 
assess not only the vascular lumen (“luminogram”) but also the vessel wall and the 
plaque2.  
High spatial resolution Magnetic Resonance Imaging (HR-MRI) has been used to study 
human atherosclerotic lesions in several vascular beds, and its accuracy and 
reproducibility in measuring atherosclerotic plaques has been reported3-6. “Ex vivo” and “in 
vivo” studies in animals and in humans have clearly demonstrated the high potential of 
MRI in evaluating atherosclerotic plaques in different vascular territories non-invasively7, 8. 
In addition, MRI can safely assess the effects of drugs and/or mechanical treatments, such 
as the action of statins or balloon angioplasty9, 10. Few studies have simultaneously 
compared the natural course of atherosclerosis of two different vascular beds (carotid and 
aorta or carotid and coronary arteries)11, and, to our knowledge, no previous prospective 
study using HR-MRI plaque imaging at the level of both carotid and femoral arteries has 
been conducted to quantify the evolution of atherosclerosis11, 12. 
In this prospective study, we aimed to evaluate both carotid and femoral levels intra-
individually in patients with a high Framingham cardiovascular risk score using HR-MRI. 
 
 
4. METHODS 
Study population 
Patients were recruited from our outpatient vascular clinic, where they were evaluated for 
carotid and femoral artery disease. Screening was performed using duplex ultrasound of 
the extracranial cerebral arteries. Patients were considered eligible for inclusion in the 
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protocol if they presented with an asymptomatic <70% carotid artery stenosis. Patients 
were not eligible for the study if they had non-atherosclerotic occlusive disease, severe 
claustrophobic reactions or short-term life-threatening pathology (life expectancy less than 
12 months), or were pregnant. Only patients who underwent the complete protocol with 
plaque HR-MRI of both carotid and femoral arteries at each time point (baseline, 1-year 
and 2-year follow-up) were considered for statistical analysis. The study complies with the 
Declaration of Helsinki, the local ethics committee approved the protocol and the patients 
gave their informed consent. 
Baseline examination included: medical history, cardiovascular examination, and 
laboratory analysis(hemoglobin, hematocrit, total white blood cells, platelets, creatinin, 
HbA1c-glycosylated hemoglobin, cholesterol profile, hs-CRP, homocystenin, and 
microalbuminuria) as well as blood sampling for potential evaluation of additional future 
markers and duplex ultrasound of the epiaortic arteries. All the patients were treated with 
standard medical care. 
 
High-Resolution Magnetic Resonance Imaging 
The MRI protocol included the completion of HR-MRI of both the carotid and femoral 
arteries at baseline and at 1- and 2-year follow-up, totaling six scans per patient. As 
specified by the study protocol, only patients who completed the entire 2-year follow-up, 
including the full HR-MRI examination of both carotid and femoral arteries, were 
considered for final evaluation. HR-MRI scanning of the carotid and femoral arteries was 
performed as a separate investigation within a time frame of less than 2 weeks. A 1.5-
Tesla unit (Gyroscan Intera, release 11; Philips Medical Systems, Best, The Netherlands) 
with a gradient strength of 30 mT/m and a slew rate of 150 mT/m/ms was used. 
For imaging of the carotid arteries, a bilateral, four channel, phased-array (receive only) 
coil (Machnet BV, TD Elde, The Netherlands) was carefully positioned at the level of the 
carotid bifurcation and used for all data collection. The protocol started with scout images 
and a 2-D time-of-flight MR-angiography sequence to localize the carotid bifurcations. This 
was followed by a sagittal T1-weighted (T1w), double inversion recovery, fast spin echo 
(2IR-FSE) sequence at the level of the index common carotid artery bifurcation to allow 
precise localization of the bifurcation, plaque extension and therefore reproducible 
planning of the subsequent MR images (Figure 1). The 2IR-FSE sequence allows nulling 
of the signal from the flowing blood and is known as blackblood MRI. Axial, 2-dimensional, 
ECG-triggered, 2IR-FSE sequences centered at the index carotid artery bifurcation using 
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T1w, proton density-weighted (PDw) and T2-weighted (T2w) imaging sequences with 
spectral fat saturation were performed using the following parameters: slice thickness, 2 
mm; number of slices, 12; acquired in plane resolution, 0.63x0.63mm (reconstructed 
0.31x0.31mm); NSA, 2; repetition time (TR), 1RR interval for T1w and 3 RR for PDw and 
T2w; echo time (TE), 7, 12, and 50 ms for T1w, PDw and T2w images, respectively. In 
addition, an axial 3D TOF sequence was acquired in the same position as the 2IR-TSE 
sequences with the following imaging parameters: number of slices, 12; slice thickness, 
2mm; acquired in plane resolution, 0.63x0.63mm (reconstructed 0.31x0.31mm); NSA, 2; 
TR, 23; TE, 2.1; flip angle, 25°. 
 
Femoral artery MRI studies were performed in separate imaging sessions using a 
previously described imaging protocol 10. The MRI protocol consisted of 3 steps: (1) 
gradient echo (scout) series to localize anatomic structures; (2) time-of-flight MRI 
angiography to localize the stenotic lesion of interest and to define the precise location of 
the index stenosis by measuring the distance from femoral artery bifurcation to the lesion 
of interest, therefore allowing reproducible positioning of (3) plaque imaging sequences in 
all follow-up studies (Figure 1). Three-dimensional T2w, PDw, T1w, ECG-triggered, 2IR-
FSE sequences were used to acquire cross-sectional images of the vessel wall with the 
following parameters: slice thickness, 2.5 mm; number of slices, 10; acquired in plane 
resolution, 0.35x0.42mm (reconstructed 0.18x0.18mm); NSA, 2; TR, 1RR interval for T1w 
and 2-3 RR for PDw and T2w, respectively; TE, 9.4ms for T1w and PDw and 40ms for 
T2w images; echo train length was 6 for T1w and 24 for PDw and T2w images. Spectral 
suppression was used for black blood images (T1w, PDw, and T2w) to reduce signal from 
subcutaneous fat. Spatial presaturation slabs were used to eliminate aliasing resulting 
from the small field of view (90x90mm). In order to obtain optimized signal to noise ratio, a 
small circular superficial receive-only coil (diameter 8 cm), centered at the region of 
interest, was used for all 2IR-FSE sequences. The index femoral lesions were located 
from the level of femoral bifurcation to the distal femoral artery. If no clear atherosclerotic 
lesion was detected on the time-of-flight MRI angiography during the baseline study high-
resolution plaque imaging sequences were centered at the level of the common femoral 
artery bifurcation. The approximate duration of the MR study was 40-50 min for the carotid 
and 35-45 min for the femoral artery. 
 
Duplex ultrasound imaging 
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A single experienced ultrasonographer performed all Duplex examinations with a 7 MHz 
linear-array transducer on a Sequoia 512 unit (Acuson Inc. Mountain View, CA, USA) at 
our outpatient vascular unit during the screening phase, at baseline and at 1and 2 year 
follow-up. The examination was performed with the patient in the supine position with the 
head resting on a support pillow for at least 15 minutes. Sites of examination included the 
key lesion, the common carotid artery and the internal carotid artery. The study was 
started low in the neck by visualizing the common carotid artery along its longitudinal axis. 
The transducer was then moved toward the base of the skull to identify the carotid bulb 
and the internal and external carotid arteries. For carotid artery stenosis, estimation of 
obstruction was completed using B-mode evaluation in short- and long-axis as well as 
previously described semi quantitative Doppler assessment 13-15. 
 
Image analysis 
MRI studies were transferred from a PACS/RIS system (Philips Medical Systems, Best, 
The Netherlands) to a dedicated software program (GTVolume v.1.3 for Windows, 
GyroTools Ltd., Switzerland) used to analyze the morphometrics of the cross-sectional MR 
images with the aid of a touch screen device (pen display DTU-1931, Wacom Co. Ltd.). 
Two trained reviewers (a radiologist with 8 years of experience in Magnetic Resonance 
plaque imaging and one research fellow with one year of experience) evaluated the 
images in consensus. 
To further maximize co-registration among follow-up studies, meticulous alignment of the 
images was performed before final evaluation according to the level of the carotid 
bifurcation or of identical external anatomical landmarks (e.g., small veins on images of the 
femoral artery) as shown in Figure 2. At the carotid level, all matched images from 
common to internal carotid artery present in each follow-up examination were used for 
further analysis. 
Luminal area (LA) was defined as the area encompassed by the inner boundary of the 
intimal surface. Total vessel area (TVA) was defined by the outer boundary of the vessel. 
Vessel wall area (VWA) was calculated by the software subtracting TVA minus LA 
(VWA=TVA-LA). These parameters are outlined in Figure 3. LA and TVA were assessed 
on T1w images; if image quality was not sufficient, T2w or PDw images were used instead 
16. Images with poor quality were excluded from evaluation. A normalized wall index was 
then calculated (NWI=VWA/TVA). Interreader and intrareader reproducibility were 
evaluated for ten randomly selected patients at both carotid artery and femoral artery 
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levels for a total of 20 segments. Intraclass correlation coefficient for the agreement 
between two operators/two repeated measures were calculated with 95% confidence 
interval for the TVA, LA and VWA.  
 
Data management and statistical analysis 
Summary statistics are shown as the mean of the values ±SD. The means of 
morphometric variables are intended as a sum of all areas divided by the number of slices 
summarized across all subjects. Two intermediate missing values were replaced by the 
mean of extremes. Only data from location-matched images were considered for analysis. 
Changes are presented as mean evolution between visits and as annualized rates both for 
absolute and percent values. Evolutions between visits were analyzed using ANOVA for 
repeated measures and the comparison of annual change to zero using one sample t-test. 
Values were tested for normal distribution. Statistical significance was defined as a value 
of p<0.05, two-tailed. All graphs and calculations were performed using SPSS 18.0 and 
GraphPad Prism. Data management was performed with Filemaker Pro v10.0v3. 
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5. RESULTS 
 
Forty-five patients screened by Duplex ultrasound between June 2006 and March 2008 
were considered for MRI plaque imaging. Thirty patients underwent the complete MRI 
protocol of both carotid and femoral plaque at baseline, 1- and 2-year follow-up. In total, 
this led to 178 MRI studies (one patient missed at the 1-year carotid and femoral follow-up 
visit). Five patients chose not to continue with the follow-up studies (two of them presented 
with claustrophobia), four patients had to be excluded because of limited image quality, 
three patients died, two patients underwent stenting because of plaque progression (one 
at carotid and one at femoral levels), and one patient could not complete the follow-up due 
to pace-maker placement. 
 
Clinical data 
The majority of patients were more than 55 years old and presented mild to moderate 
increase in arterial blood pressure despite pharmacological treatment. Half presented with 
a history of CAD, more than 65% were smokers or ex-smokers and a third of patients 
suffered from diabetes mellitus. Hyperlipidemia was present in >90% of the patients, and, 
despite antilipidemic drugs, the mean cholesterol LDL level at baseline was 2.9 mmol/l (± 
0.96) and 2.44 mmol/l (± 0.87) at the second year (p=0.03). Sixty-eight percent of the 
patients were on statin therapy for more than two years. Other baseline characteristics, 
medication and laboratory results of the population were stable during follow-up and are 
shown in Table 1.  
 
HR-MRI 
A total of 1068 HR-MRI cross-sectional images of the carotid arteries (360 at BL, 348 at 1y 
and 360 at 2y) and 890 cross sections at the level of the femoral arteries (300 at BL, 290 
at 1y, 300 at 2y) were evaluated. Mean follow-up time was 2.18 (± 0.19) years at the 
carotid level and 2.16 (± 0.18) years at the femoral level. Mean interval time between 
carotid and femoral HR-MRI was 9.3 days (± 31.7). Progression during the 2 year follow-
up is shown in Figure 4. At the carotid level, LA decreased (-3.19%/year, p=0.018) while 
VWA increased (+3.83%/year, p=0.019) and TVA remained unchanged. At the femoral 
level, LA remained unchanged, while VWA and TVA increased (+5.23%/year and 
+3.11%/year, both p<0.05). NWI increased for both carotid (+2.28%/year, p=0.01) and 
femoral (+1.8/year, p=0.033) arteries. The detailed data of LA, VWA and TVA as assessed 
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by HR-MRI are provided in Table 1. Figure 5 shows an example of HR-MRI cross-sections 
in the same patient at the level of the carotid and femoral artery at baseline and during 
follow-up. The distinct remodeling process is emphasized in the schematic representation 
(Figure 6). Interobserver intraclass correlation coefficients (ICC) of TVA, LA and VWA 
were respectively 0.99 (95 % CI: 0.96 - 0.99), 0.97 (0.93 - 0.98) and 0.97 (95% CI: 0.91 - 
0.98) and intraobserver ICC were 0.98 (95% CI: 0.96 - 0.99), 0.97 (95%CI: 0.94 - 0.99) 
and 0.96 (95%CI: 0.90 - 0.98). 
 
Duplex 
Duplex ultrasound of the index carotid arteries (Table 2) revealed progression of the 
degree of stenosis at the carotid level of +3.3 %/year (±5.3%). The degree of arterial 
obstruction at baseline in the two vascular territories was different: at the carotid arteries 
53% of patients had a stenosis of >50%, whereas at the femoral level, only 22% of the 
patients had a stenosis of > 50%. 
 
Clinical follow-up and morphometric values 
The Framingham general cardiovascular disease 10-year risk score at baseline was 
29.5%. In the 45 patients who were initially included, we observed three deaths, seven 
cerebrovascular events and seven acute coronary syndromes. There was no statistically 
significant correlation between the morphometric MRI parameters and the occurrence of 
clinical cardiovascular events.  
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6. DISCUSSION 
Our “in vivo” prospective study on the natural history of atherosclerosis progression using 
serial high-resolution magnetic resonance imaging indicates that the atherosclerotic 
burden increases in both the carotid and femoral arteries. However, atherosclerosis 
presents a distinct intra-individual pattern of progression in the two arterial territories, with 
a negative remodeling at the level of the obstructed carotid artery and a positive 
remodeling at the level of the femoral arteries. To our knowledge, this is the first 
prospective study that systematically assessed progression of atherosclerotic burden intra-
individually by HR-MRI at both carotid and peripheral levels on a yearly basis. The results 
showed an increase of the mean vessel wall area (+3.83%/year) at the level of the carotid 
arteries and a reduction in lumen area (-3.19 %/year) despite standard medical care 
(Table 1), whereas, at the femoral level, the increase in vessel wall area (+5.23%/year) 
was not accompanied by a decrease of the lumen area (Figures 4 and 5). This distinct 
pattern of vascular remodeling in two different vascular beds within the same patient could 
have several explanations. The observed differences between the two territories in our 
study may be related to anatomic and flow differences, such as vessel dimensions, 
tortuosity, bifurcation, and diverse flow conditions (high and low resistance flows at the 
femoral and carotid levels, different streamlines and shear stress). Conversely, the 
different remodeling behaviors in our patients in the two territories cannot be related to 
differences in medical therapy, risk factors or genetic profile because biological differences 
were excluded by our study design, with intra-individual comparison of two different 
vascular territories by HR-MRI. Another plausible explanation for the different remodeling 
patterns is the distinct degree of obstruction at the two vascular locations. This explanation 
is in accordance with the Glagov paradigm17: Our patients presented a more advanced 
degree of obstruction at the level of the carotid arteries, and, consistent with Glagov, the 
vessel wall area increased while the lumen area decreased. Conversely, at the level of the 
femoral arteries, with a lesser degree of obstruction of the vessel wall, the progression of 
the atherosclerotic plaque continued to underlie a positive remodeling with significant 
increase of the vessel wall area albeit without concomitant increase of the obstruction.  
Hayashi et al. have recently reported retrospective data of patients who eventually 
underwent HR-MRI at the level of the thoracic-abdominal aorta and carotid arteries11, 
indicating a possible distinct progression pattern in the various territories. In contrast, our 
prospective data definitely point to the differential behavior of atherosclerosis according to 
its localization and stage. 
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At the level of the carotid arteries, our results are in agreement with the recent data of 
Saam et al 18. Surprisingly, we found a positive remodeling with augmentation of vessel 
wall area and preservation of the lumen area at the level of the femoral arteries. This is in 
contrast with the post mortem findings of Pasterkamp et al and of Li et al using HR-MRI, 
who both found that the constrictive remodeling pattern was more prevalent at the level of 
the peripheral arteries than at the level of the coronary and carotid arteries 19, 20. This can 
partially be explained by the high degree of femoropopliteal obstruction among their 
patients when compared with our cohort, in which only 22% of patients had a femoral 
obstruction >50%. 
Carotid and peripheral arteries - like the coronary arteries- may undergo circumferential 
changes in response to atherosclerotic lesion formation 17, 19. Arterial remodeling remains 
a major determinant of luminal narrowing in all vascular beds; a deterministic mechanism 
for maintaining patency of the lumen in the presence of atherosclerosis. Conversely, there 
is evidence that arteries undergoing an important positive remodeling harbor a high risk of 
complications and are more prone to plaque complications, such as plaque rupture with 
exposure of the lipid rich core or plaque hemorrhage. Although our project was not 
focused on acute ischemic cerebral complications, this underlines the relevance of plaque 
composition and the potential of HR-MRI in detecting plaque complication as recently 
emphasized 21. 
The prevalence and clinical presentation of expansively remodeled lesions may differ 
depending on location within the arterial tree, as indicated not only by our results but also 
according to the location along the vessel. HR-MRI constitutes an ideal tool to study acute 
and chronic remodeling at the level of the carotid and lower limb arteries “in vivo” and non-
invasively. Using the same technique, we recently reported on acute and long-term “in 
vivo” vascular effects in patients undergoing endovascular therapy of the lower limb 
arteries10, 22. 
 
Study limitations 
The relatively small cohort of patients in this study does not allow extrapolation of our 
results to a larger cohort and this is the main limitation of the study.  We are aware that the 
observations in our study refer to mean values of the HR-MRI-derived parameters 
obtained from selected arterial segments. Therefore, the results may neither reflect 
systemic remodeling nor regional effects in the same vessel segment.  
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There was a trend to progression of TVA at the level of the carotid artery although not 
significant (p=0.089) the power of the test being only 55%. In order to show a significant 
increase with power of 80%, sixty patients would have been necessary, a number of 
patients far beyond the possibilities of the present very demanding protocol. 
Our study design with recruitment of patients based primarily on asymptomatic < 70% 
carotid stenosis led to the fact that the degree of stenosis was more advanced in the 
carotid than in the femoral arteries which may contribute to the distinct progression of 
atherosclerosis between these vascular territories.  
The LDL cholesterol levels at entry were higher than those recommended for secondary 
prevention in CAD and only approximately two thirds of patients were on statins for more 
than two years at the time they were included in the study: these two factors could explain 
the lack of regression of atherosclerosis as found in previous studies23, 24. 
The relatively high number of patients (15 of 45) that dropped-out of the study represents 
another limitation, however this appears to be in accordance with previous studies 25.  
Our study focused on progression of atherosclerosis based on measurements of lumen 
and vessel wall area, but we did not assess plaque components since adequate image 
quality is mandatory in all imaging sequences in order to perform reliable analysis of 
plaque composition. This would have lead to further drop-out of a significant number of 
studies reducing thereby furthermore the number of patients with a complete set of follow-
up studies and therefore meaningful statistical evaluation would have likely become 
impossible. In addition, 3D volume imaging acquisition at the level of the carotid arteries 
was not performed because it was not feasible at that time. 
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Conclusions 
Despite a standard medical care the atherosclerotic burden increases significantly and 
similarly in both carotid and femoral arteries. However, carotid arteries show a pattern of 
remodeling that is distinct from that of femoral arteries. This finding, which needs to be 
confirmed in further studies, could be related to anatomic and flow differences between the 
two arterial territories and/or to the different degrees of obstruction. 
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9. FIGURES LEGENDS 
 
Figure 1) MRI method for serial plaque imaging 
Left: sagittal HR-MRI image at the level of the carotid bifurcation shows an extensive 
atherosclerotic plaque with positive remodeling of the internal and common carotid artery 
[T1w, double inversion recovery (2IR)]. The yellow box indicates positioning of subsequent 
axial HR-MRI sequences. Right: MRI method for serial plaque imaging at the femoral level. 
After localization of the stenosis of interest, a 3D volume (yellow box), containing 10 
contiguous cross-sectional images perpendicular to the lumen axis was acquired and 
carefully matched over time using measurements from anatomical landmarks (such as 
common femoral artery bifurcation). Manual tracing of vessel border (lumen in red and 
outer border in blue) was performed to quantify vessel dimensions (lower panel). Outer 
vessel border defined the total vessel area (TVA). V: Femoral vein. 
 
Figure 2) Matching of MRI images at level of the carotid artery over time 
Matching of the axial MRI images from baseline to 2-year follow-up on the basis of 
reference anatomic landmarks, e.g., carotid bifurcation (arrowhead) allowed correct 
alignment of the slices. 
 
Figure 3) Carotid artery tracing 
Atheromatous plaque of the internal carotid artery: lumen area (LA - red line) and total 
vessel area (TVA - blue line) are manually outlined. Vessel wall area (VWA=TVA-LA) is 
calculated by the software. Also note the external carotid artery (ECA) and right jugular 
vein (JV). 
 
Figure 4) Line graphs of atherosclerotic progression 
Evolution of mean lumen area (LA), vessel wall area (VWA) and total vessel area (TVA) at 
the carotid (left) and femoral (right) levels; plots with error bars (95%CI). 
 
Figure 5) Example MRI of both territories 
Top: axial MR images [T1w -2IR] at the level of the internal carotid artery at BL; 1- and 2-
year follow-up shows a negative remodeling with moderate luminal narrowing. Bottom: 
axial oblique plane HR-MRI images of the common femoral artery (3D-T1w-2IR) of the 
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same patient showing eccentric atherosclerotic remodeling at baseline, 1- and 2-year 
follow-up. 
 
Figure 6) Schematic representation of remodeling 
Remodeling at the level of the carotid and femoral arteries has been emphasized in order 
to show the evolution. 
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10. TEXT TABLES 
Table 1) Clinical data of the analyzed population (n=30): demographics, medications, 
medical history and laboratory results (*=median, first and third inter-quartile value for data 
with non normal distribution). 
 
 
Table 2) HR-MRI (morphologic values) and duplex results (stenotic degree) at the carotid 
level and (morphologic values) at the femoral level. p-values from one-way ANOVA 
(repeated measures) for the mean values and t-test of the annualized (delta/year) absolute 
values. 
 
